Skip to main content
Clinical Trials/KCT0008806
KCT0008806
Recruiting
N/A

Evaluation of association of vascular aging, chronic inflammation and degenerative brain disease

Gachon University Gil Medical Center0 sites350 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mental and behavioural disorders
Sponsor
Gachon University Gil Medical Center
Enrollment
350
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Alzheimer's Disease (AD): Participants with a Clinical Dementia Rating (CDR) of 0\.5 or higher and who meet the DSM\-IV\-TR criteria for dementia and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS\-ADRDA) criteria for probable or possible AD.
  • \-Subcortical Vascular Dementia (SVaD): Participants with a CDR of 0\.5 or higher, who meet the DSM\-IV criteria for vascular dementia, and show moderate or higher white matter changes on MRI FLAIR imaging based on the modified Fazeka's scale.
  • Mild Cognitive Impairment (MCI)
  • : Participants with a Clinical Dementia Rating (CDR) of 0\.5, but without dementia according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text\-revision (DSM\-IV\-TR) criteria.
  • Cognitively Normal
  • : Participants with a Clinical Dementia Rating (CDR) of 0 and without objective evidence of cognitive decline (less than \-1\.5 standard deviations) based on comprehensive neuropsychological test.

Exclusion Criteria

  • \-Pregnant women (Excluded if even slightly suspected of being pregnant based on surveys or menstrual cycle information)
  • \-Women currently breastfeeding
  • \-Patients with severely compromised overall health to the extent that conducting tests is difficult
  • \-Individuals with seizure disorders such as claustrophobia or other major neurological conditions, such as traumatic brain injury, Parkinson's disease, \-Huntington's disease, motor neuron diseases, multiple sclerosis, etc.
  • (Note: Exclusion is only considered if the study director (physician) deems it would significantly affect the study.)
  • \-Patients diagnosed with psychiatric disorders such as schizophrenia
  • \-Patients with brain tumors, hydrocephalus, encephalitis, or metabolic encephalopathy
  • \-Women who are currently pregnant or using intrauterine contraceptive devices
  • \-Individuals deemed inappropriate for the study by the clinical researcher
  • \-Persons with cardiac pacemakers or metallic implants within the body

Outcomes

Primary Outcomes

Not specified

Similar Trials